Hemosiderosis other diagnostic studies

	Hemosiderosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemosiderosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemosiderosis other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemosiderosis other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemosiderosis other diagnostic studies
CDC on Hemosiderosis other diagnostic studies
Hemosiderosis other diagnostic studies in the news
Blogs on Hemosiderosis other diagnostic studies
Directions to Hospitals Treating Hemosiderosis
Risk calculators and risk factors for Hemosiderosis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Other diagnostic studies for IPH include sputum testing and bronchoalveolar lavage (BAL) for intact erythrocytes and hemosiderin-laden macrophages, which demonstrate pulmonary hemorrhage, and pulmonary function tests, which generally shows a restrictive pattern of varying severity and decreased DLCO.